Introduction {#sec1-1}
============

Edible bird's nest (EBN) is a well-known bioproduct made from the saliva secretion of swiftlet, specifically from the two genera of *Aerodramus* and *Collocalia*. The swiftlet from the two genera is mostly habitat in Southeast Asia \[[@ref1],[@ref2]\]. The main constituents of EBN are proteins, carbohydrates, lipids, and a group of minerals such as calcium, sodium, potassium, magnesium, phosphorus, iron, zinc, copper, chromium, and selenium \[[@ref2]-[@ref5]\]. EBN has been regarded as traditional Chinese medicine by the practitioners in Qing dynasty due to its recuperative properties \[[@ref1],[@ref6]\]. The recuperative properties of EBN are highlighted with the effect of boosting immune system, treating malnutrition, improving metabolism, enhancing skin complexion and alleviating asthma, helping in phlegm clearance, relieving cough, nourishing children, libido raising, enhancing renal function, recovery from illness and surgery, as well as improving concentration \[[@ref7]\]. Recently, EBN is further demonstrated for its properties on suppressing the virus, inflammation and oxidative stress, strengthening bone, eye caring, and neuroprotective properties \[[@ref8]-[@ref14]\]. On the other hand, Roh *et al*. \[[@ref15]\] and Kong *et al*. \[[@ref16]\] have reported the proliferative effects of EBN on human adipose-derived stem cells and normal human fibroblasts with the presence of epidermal growth factor-like activity. In summary, EBN acts as a dual function bioproduct with both its nutritional and therapeutic values.

To study the constituents of EBN and its therapeutic effects, the development of an ideal extraction methodology of EBN is very important. Several extraction methodologies were developed and used for studying the bioactivities of EBN. The study by Guo *et al*. \[[@ref9]\] documented strong inhibition of influenza viruses by EBN extract that is pre-treated with pancreatin. Besides, Abidin *et al*. \[[@ref11]\] also reported that the EBN extract prepared by eHMG extraction method successfully stimulated and enhanced the proliferation of corneal keratocytes in wound healing without altering their functionality. Chua *et al*. \[[@ref17]\] prepared EBN extracts by the water extraction method (HMG). These extracts exhibited strong chondroprotective effects on osteoarthritis (OA). In addition, Aswir and Wan Nazaimoon \[[@ref18]\] have documented acid-extracted EBN exhibited an anti-inflammation effect by significantly reducing the production of the inflammatory protein, tumor necrosis factor-alpha. In view of all the works, it is observed that different EBN extract obtained through different extraction methods showed different therapeutic effects. One possible explanation is because the extraction of an active component is highly dependent on the extraction method employed. Thus far, the identity of the metabolites in each of these extractions has not yet been further studied for the underlying mechanism of actions for their therapeutic effects. Hence, future study could be carried out to confirm the therapeutic effects of the metabolites.

Metabolite profiling is a powerful scientific tool for a complete investigation of a group of small molecules. This approach often used in analyzing biological components for the identification of potential biomarkers for certain diseases \[[@ref19]\]. Recently, metabolite profiling has gained fame in food classification \[[@ref20],[@ref21]\]; this is due to its untargeted analysis approach with the potential to cover the whole or the maximum metabolomics molecular information of foods. One of the examples of using the metabolite profiling approach on EBN has successfully demonstrated in the study done by Chua *et al*. \[[@ref22]\]. The metabolites of the EBN were extracted through the chloroform/methanol solvent extraction, which was then successfully identified through gas chromatography-mass spectrometry (MS) and liquid chromatography-MS (LC-MS) techniques.

Since water is commonly used to prepare EBN essence for consumption and the metabolites of EBN are not fully established yet, this study aimed to preliminary profile the water-soluble metabolites of EBN prepared in different extraction methods. Subsequently, an extraction method will be selected as an ideal extraction method for untargeted metabolite profiling on the water-soluble metabolites in EBN.

Materials and Methods {#sec1-2}
=====================

Ethical approval {#sec2-1}
----------------

The study did not involve any live animals, so no ethical approval was required.

Chemicals {#sec2-2}
---------

LC-MS grade formic acid and acetonitrile were purchased from Fisher Scientific (Waltham, MA, USA). Deionized water was obtained from a Barnstead GenPure water purification system (Thermo Fisher Scientific Inc., Waltham, MA, USA).

Sample collection, preparation, and extraction {#sec2-3}
----------------------------------------------

Raw unclean EBNs samples were collected collectively from different swiftlet premises located in Johor, Malaysia. The feathers and impurities were manually removed with forceps, and the raw unclean EBN was ground with mortar and pestle. Ground EBN was sieved through a 0.4 mm wire mesh to further separate the smaller pieces of feathers and impurities. The unclean EBN powder was then placed in an air force oven at 50-55°C overnight to reduce the moisture content.

There were four extraction methods selected for the comparison in this study, namely, eHMG, pHMG, ABN, and EzBN extraction methods. The raw unclean EBN was extracted with the proprietary methods of eHMG \[[@ref11]\] and pHMG (the spray-dried of HMG extract) \[[@ref17]\] that were innovated and standardized by School of Chemical and Energy Engineering in Universiti Teknologi Malaysia (UTM). These methods were modified based on the methods presented by Oda *et al*. \[[@ref23]\] and Goh *et al*. \[[@ref24]\]. Besides, another acid extraction (ABN) and pancreatin extraction (EzBN) were developed by the team of Universiti Tunku Abdul Rahman (UTAR) in 2016 \[[@ref25]\] with some modification from the methods presented by Aswir and Wan Nazaimoon \[[@ref18]\] and Goh *et al*. \[[@ref9]\].

### eHMG and pHMG {#sec3-1}

Due to the proprietary issue on these two extraction methods, the details of these two methods were unable to be described in this report.

### Acid extraction (ABN) {#sec3-2}

The EBN powder was suspended in deionized water at 0.2% (w/v) and left for 24 h. The mixture was then boiled at 80°C with 2% (v/v) of 0.4 M sulfuric acid for 4 h. The extract was allowed to cool down and centrifuged at 2716 g (5000 rpm) for 15 min. The pH of the supernatant collected was neutralized to pH 7.0. The white precipitated formed was removed through centrifugation with 2716 g (5000 rpm) for 15 min at 4°C. The supernatant was collected and kept at 4°C for further analysis.

### Pancreatin extraction (EzBN) {#sec3-3}

The EBN powder was suspended in deionized water at 0.2% (w/v) and left for 24 h. The EBN mixture was boiled at 100°C for 30 min. An amount of 1 ml of 0.5 mg/ml pancreatin was added into EBN mixture and was allowed for the reaction at 45°C for 4 h with pH 8.5-9.0. The enzyme was inactivated by heating at 90°C for 10 min. The supernatant was collected after centrifugation at 2716 g (5000 rpm) for 15 min. The extract was kept at 4°C.

Before subjecting the extracts to LC-MS analysis, all the four extracts were centrifuged at 9660 g (12,000 rpm) for 10 min and the supernatant of the extracts was filtered through 0.2 µm polytetrafluoroethylene membranes.

Quadrupole time-of-flight (QTOF) LC-MS analysis {#sec2-4}
-----------------------------------------------

The four EBN extracts were qualitatively analyzed using Agilent 6560 Ion Mobility QTOF (IM-QTOF) LC-MS system that coupled with the Agilent 1290 ultra-high-performance liquid chromatography (Agilent Technologies, USA). The metabolites present in the EBN extracts were separated through POROSHELL 120 EC-C18 (4.6×100 mm; 2.7 μ; Agilent Technologies, USA) chromatographic column with the mobile phase that consisted of (A) 0.1% formic acid in water and (B) 0.1% formic acid in acetonitrile. All the four EBN extracts were undergone the first pre-screening evaluation with the elution of 5-95% B (0.0-1.0 min) and 95-5% B (1.0-15.0 min). The flow rate was set at 1.0 ml/min. The two extracts with a higher number of metabolites were selected and further subjected for the second LC-MS screening with modified mobile phase elution. The condition of the modified elution was set as follows: 5% B (0.0-2.0 min), 5-15% B (2.0-4.0 min), 15-25% B (4.0-6.0 min), 25-35% B (6.0-8.0 min), 35-45% B (8.0-10.0 min), 45-50% B (10.0-12.0 min), 50-75% B (12.0-16.0 min), 75-100% B (16.0-20.0 min), 100-5% B (20.0-20.1 min), and isocratic at 5% (20.1-25 min). The flow rate was modified to 0.3 ml/min.

The other setting parameters for IM-TOF analysis remained the same throughout the analysis process. The injection volume was 1 µl and the column temperature was maintained at 40°C. The acquisition of the metabolites was performed in positive (ES+) mode. The mass spectra were recorded over an m/z range from 100 to 1000. Deionized water was used as the background blank. Whereas, the operating conditions of the mass spectrometer were set as follows: Capillary voltage of 4000 V, nozzle voltage of 500 V, and fragmentor voltage of 365 V were maintained. Nebulizer pressure (N~2~) was kept at 20 psi, drying gas temperature was maintained at 225°C. Drying gas flow was 13 L/min and sheath gas flow was 12 L/min at 400°C.

Data mining and metabolites identification {#sec2-5}
------------------------------------------

The metabolite features from the acquired MS spectral raw data were extracted with the untargeted molecular feature extraction algorithm in Agilent MassHunter Workstation - Qualitative Analysis software B.07.00 (Agilent Technologies, USA). The algorithm filtered off the peak height with 100 counts to avoid the noise spectral picking, as well as the mass of internal reference ions with 121.0967 and 922.1389. Then, the algorithm locates the covariant ions in the chromatogram and grouped them as a single metabolite feature using the information of mass, isotopic distribution with common organic elements (C, H, O, N, P, Cl, F, and S), charge-state and adducts of sodium, potassium, and ammonium. The extracted metabolite features were characterized by retention time (RT) and intensity.

The identity of the extracted metabolite features was searched against METLIN Personal Metabolite Database in the MassHunter software based on the accurate mass and RT (optional). The mass and RT tolerance of the compound identity matching was restricted to ±5 ppm and ±0.1 min (optional), respectively. The accuracy of the identity of each metabolite was calculated as a score. The metabolites list of each extract was retained if the identity of the metabolite fulfilled the threshold score of 80, and the error of database matching was less than ±5 ppm.

Results and Discussion {#sec1-3}
======================

The efficiency of EBN extraction methods {#sec2-6}
----------------------------------------

The method of extraction is a crucial process that maximizes the extraction of the bioactive metabolites from EBN. To search for an ideal extraction method for the untargeted metabolite profiling of EBN, four different extraction methods with the therapeutic effects were assessed and evaluated. For example, pancreatin extraction with antiviral effect as reported by Guo *et al*. \[[@ref9]\]; eHMG extraction with the effect of enhancing proliferation of corneal keratocytes by Abidin *et al*. \[[@ref11]\]; HMG extraction showed chondroprotective effect on OA as documented by Chua *et al*. \[[@ref17]\]; and finally the acid extraction with anti-inflammation bioactivities reported by Aswir and Wan Nazaimoon \[[@ref18]\]. The approach of LC-MS is recognized with its high sensitivity, accuracy, and reproducibility \[[@ref26]-[@ref28]\]; thus, there was no technical replicate done in this untargeted metabolite profiling analysis.

The number of detected metabolites in each of the extraction method was analyzed by MassHunter software. Nearly 37-67% out of the total metabolites from the four different extracts were putatively identified by matching with the METLIN metabolites database. The complete information of all the identified metabolites in each extraction method is detailed in [Table-1](#T1){ref-type="table"}. The identities of the extracted metabolites are unique among the four different extracts, suggesting that there is no single extraction method that could extract all types of metabolites due to the differences in natural physicochemical properties of the metabolites \[[@ref29]-[@ref32]\].

###### 

Information of the metabolites in each extracts with first pre-screening by QTOF LC-MS.

  Number     RT (min)   Ion            Mass       m/z        Molecular formula    Score   DB differences (ppm)   Putatively identified metabolites
  ---------- ---------- -------------- ---------- ---------- -------------------- ------- ---------------------- ---------------------------------------------
  1          1.001      (M+NH~4~)^+^   104.0375   122.0713   C~6~H~4~N~2~         85.65   −0.48                  4-Cyanopyridine
  2          1.005      (M+H)^+^       273.1082   274.1154   C~9~H~15~N~5~O~5~    97.11   −3.06                  4a-Peroxy-tetrahydrobiopterin
  3          1.005      (M+H)^+^       291.1206   292.1278   C~14~H~17~N~3~O~4~   89.12   4.47                   Serinyl-Tryptophan
  4          1.005      (M+H)^+^       309.1332   310.1406   C~17~H~18~F~3~NO     87.45   2.62                   Fluoxetine
  5          1.039      (M+Na)^+^      325.0796   348.0687   C~14~H~15~NO~8~      84.49   0.49                   Pancratistatin
  6          1.083      (M+Na)^+^      291.0943   314.0835   C~11~H~17~NO~8~      95.46   3.83                   2-Deoxy-2,3-dehydro-N-acetylneuraminic acid
                                                                                                                 
  **EzBN**                                                                                                       
                                                                                                                 
  1          1.502      (M+H)^+^       109.0643   110.0715   C~5~H~7~N~3~         85.25   −2.46                  2-Aminomethylpyrimidine
                                                                                                                 
  **eHMG**                                                                                                       
                                                                                                                 
  1          0.741      (M+H)^+^       379.1125   380.1197   C~14~H~21~NO~11~     83.05   −2.62                  Chondroitin
  2          0.924      (M+Na)^+^      333.1523   356.1415   C~13~H~23~N~3~O~7~   80.80   3.82                   Ser Asp Leu
  3          1.007      (M+H)^+^       385.2081   386.2152   C~15~H~27~N~7~O~5~   83.05   −1.87                  Asn Pro Arg
  4          1.042      (M+H)^+^       311.1692   312.1764   C~12~H~21~N~7~O~3~   91.60   4.34                   Arginyl-Histidine
  5          1.112      (M+H)^+^       344.2172   345.2244   C~14~H~28~N~6~O~4~   84.88   0.07                   Gly Ile Arg
  6          1.138      (M+NH~4~)^+^   384.2144   402.2484   C~20~H~32~O~7~       81.25   1.10                   Cinnzeylanol
  7          1.311      (M+H)^+^       387.2238   388.2313   C~15~H~29~N~7~O~5~   94.39   −2.03                  Arg Asn Val
  8          1.383      (M+H)^+^       373.2333   374.2405   C~16~H~31~N~5~O~5~   81.27   −2.19                  Lys Asn Leu
  9          4.299      (M+H)^+^       654.3986   655.4060   C~35~H~58~O~11~      93.38   −1.00                  Filipin III
  10         4.316      (M+H)^+^       130.0741   131.0813   C~5~H~10~N~2~O~2~    87.43   1.25                   L-cis-3-Amino-2-pyrrolidinecarboxylic acid
  11         4.342      (M+H)^+^       114.0433   115.0505   C~4~H~6~N~2~O~2~     86.61   −3.03                  Muscimol
                                                                                                                 
  **pHMG**                                                                                                       
                                                                                                                 
  1          1.019      (M+H)^+^       166.0270   167.0344   C~8~H~6~O~4~         85.71   −2.59                  3-Formylsalicylic acid
  2          1.020      (M+Na)^+^      383.1430   406.1321   C~14~H~25~NO~11~     98.38   −0.64                  Lacto-N-biose I
  3          1.022      (M+Na)^+^      309.1065   332.0956   C~11~H~19~NO~9~      82.57   −1.76                  N-Acetyl-b-neuraminic acid
  4          1.023      (M+Na)^+^      325.0792   348.0685   C~14~H~15~NO~8~      82.22   1.85                   Pancratistatin
  5          1.024      (M+H)^+^       203.0798   204.0870   C~8~ H~13~NO~5~      86.39   −1.97                  N2-Acetyl-L-aminoadipate
  6          1.026      (M+Na)^+^      291.0960   314.0851   C~12~H~13~N~5~O~4~   84.24   2.72                   Toyocamycin
  7          1.075      (M+Na)^+^      291.0954   314.0847   C~11~H~17~NO~8~      83.71   0.12                   2,7-Anhydro-alpha-N-acetylneuraminic acid
  8          1.314      (M+H)^+^       137.0478   138.0551   C~7~H~7~NO~2~        87.40   −1.17                  2-Pyridylacetic acid
  9          1.319      (M+Na)^+^      145.0770   168.0660   C~9~H~9~N~2~         81.66   −2.63                  4-Aminomethylindole
  10         1.402      (M+H)^+^       245.1385   246.1457   C~10~H~19~N~3~O~4~   81.33   −3.66                  Asn Leu
  11         1.514      (M+H)^+^       135.0544   136.0617   C~5~H~5~N~5~         84.12   0.94                   Adenine
  12         1.542      (M+NH~4~)^+^   256.0582   274.0920   C~11~H~12~O~7~       93.89   0.53                   Piscidic Acid
  13         5.692      (M+H)^+^       101.0840   102.0912   C~5~H1~1~NO          87.59   0.67                   2-Methylpropanal O-methyloxime

RT=Retention time, DB=Database, LC-MS=Liquid chromatography-mass spectrometry, QTOF=Quadrupole time-of-flight

Based on the mobile phase for compound separation in the first screening evaluation, there were significant differences in the number of extracted metabolites under each extraction method ([Table-2a](#T2){ref-type="table"}). The highest total number of metabolites obtained was from pHMG extract and followed by eHMG extract. The total number of metabolites detected in both of pHMG and eHMG extracts was greater than EzBN and ABN extracts, with approximately 20-30 times and 4-5 times, respectively. However, the LC-MS separation for each extract was not well defined by referring to the chromatograms obtained ([Figure-1](#F1){ref-type="fig"}). Therefore, the second screening evaluation was carried out with an improved LC-MS mobile phase. Both of the eHMG and pHMG extraction methods were selected to undergo the second screening evaluation since they showed greater efficacy in extracting the higher number of metabolites from EBN in the first screening evaluation.

###### 

Number of metabolites detected and identified by QTOF LC-MS in each of the extracts for the first prescreening and the second screening with the optimized LC-MS parameters.

  Extracts                                           Total metabolites   Putatively identified metabolites   Metabolites after filtering[\*](#t2f1){ref-type="table-fn"}
  -------------------------------------------------- ------------------- ----------------------------------- -------------------------------------------------------------
  \(a\) First pre-screening                                                                                  
   ABN                                               18                  7                                   6
   EzBN                                              3                   2                                   1
   eHMG[\*\*](#t2f2){ref-type="table-fn"}            69                  26                                  11
   pHMG[\*\*](#t2f2){ref-type="table-fn"}            85                  34                                  13
  \(b\) Second screening with optimized parameters                                                           
   eHMG                                              775                 468                                 193
   pHMG                                              168                 96                                  42

Metabolites filtering is based on the presence of contaminants, the score and database matching error (ppm).

The extracts were selected for the second screening with the optimized LC-MS parameters. LC-MS=Liquid chromatography-mass spectrometry, QTOF=Quadrupole time-of-flight

![Total ion chromatograms of the first liquid chromatography/mass spectrometry (LC-MS) pre-screening on edible bird's nest extraction methods (a) ABN, (b) EzBN, (c) eHMG, and (d) pHMG. The LC-MS chromatograms are obtained from ES+mode.](Vetworld-13-304-g001){#F1}

The second screening evaluation with an optimized LC-MS mobile phase for separating compounds has greatly improved the elution efficacy and increased the number of analyzed metabolites ([Figure-2a](#F2){ref-type="fig"} and [b](#F2){ref-type="fig"}). The good separation in the liquid chromatography has broadened the range of eluted metabolites. Hence, the second screening evaluation has provided a better comparison between the eHMG and pHMG extraction methods. The eHMG extraction method has successfully recovered a significant number in total extracted metabolites as compared with pHMG ([Table-2b](#T2){ref-type="table"}). There were 193 metabolites detected from eHMG extraction method ([Table-2b](#T2){ref-type="table"}), which are more than 26 non-polar metabolites detected in the study done by Chua *et al*. \[[@ref22]\]. Therefore, the eHMG extraction method was selected as the ideal extraction method because it provided the maximal recovery of the number of water-soluble metabolites present in EBN.

![The second liquid chromatography/mass spectrometry (LC-MS) screening with optimized parameters on eHMG and pHMG extracts. (a) Total ion chromatograms of eHMG and pHMG extraction methods selected from the first pre-screening. The LC-MS chromatograms were obtained from ES+mode. (b) The efficiency comparison between the first and second screening for both eHMG and pHMG extracts. (c) The number of metabolites that found similar between pHMG and eHMG extracts. The comparison was made based on the identified metabolites that the contaminant was filtered off. (d) The classification of edible bird's nest metabolites in eHMG and pHMG extracts. The classification was based on the metabolite identities after removing the contaminants.](Vetworld-13-304-g002){#F2}

The metabolite profile of extraction methods {#sec2-7}
--------------------------------------------

In the second screening evaluation, there were approximately more than half out of the total metabolites (60.39% and 57.14% of metabolites, respectively) from eHMG and pHMG extracts that were putatively identified. The information of the retained metabolites for both eHMG and pHMG extraction methods in the second screening evaluation are shown in Tables-[3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}, respectively. Based on the comparison between eHMG and pHMG extraction methods in the second screening evaluation, 24 out of the total identified metabolites were found to be similar in each extract ([Figure-2c](#F2){ref-type="fig"}). The result indicated that the eHMG extraction method not only extracted a greater number of metabolites but also there were approximately 57.14% of the metabolites from pHMG extraction method which were found to be similar to eHMG. The identities of the metabolites that found to be similar in both of the extraction methods are marked in Tables-[3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}.

###### 

Information of the metabolites in eHMG extract. The metabolites are identified by QTOF LC-MS with second screening evaluation.

  Number   RT (min)   Ion            Mass       m/z        Molecular formula         Score (DB)   DB differences (ppm)   Putatively identified metabolites
  -------- ---------- -------------- ---------- ---------- ------------------------- ------------ ---------------------- --------------------------------------------------------------------------------------------------------
  1        7.678      (M+NH~4~)^+^   188.1052   206.1388   C~9~H~16~O~4~             87.23        −1.78                  (+/−)-Ethyl 3-acetoxy-2-methylbutyrate
  2        6.351      (M+H)^+^       156.0533   157.0605   C~6~H~8~N~2~O~3~          86.21        1.11                   (S)-3-(Imidazol-5-yl)lactate
  3        9.285      (M+NH~4~)^+^   146.0481   164.0819   C~8~H~6~N~2~O             87.68        −0.82                  1(2H)-Phthalazinone
  4        7.814      (M+H)^+^       225.1118   226.1190   C~10~H~15~N~3~O~3~        85.52        −1.99                  1-(Methylnitrosoamino)-4-(3-pyridinyl)-1,4-butanediol
  5        7.154      (M+NH~4~)^+^   151.1003   169.1341   C~9~H~13~NO               85.35        −3.75                  1,2,3,4,5,6-Hexahydro-5-methyl-7H-cyclopenta\[b\]pyridin-7-one
  6        19.916     (M+H)^+^       310.2875   311.2947   C~20~H~38~O~2~            82.62        −1.10                  15Z-eicosenoic acid
  7        19.852     (M+NH~4~)^+^   168.1882   186.2220   C~12~H~24~                93.33        −2.37                  1-Dodecene[\*](#t3f1){ref-type="table-fn"}
  8        17.086     (M+H)^+^       203.0811   204.0882   C~9~H~17~NS~2~            90.55        −4.19                  1-Isothiocyanato-7-(methylthio)heptane[\*](#t3f1){ref-type="table-fn"}
  9        13.104     (M+H)^+^       115.0456   116.0528   C~5~H~9~NS                95.32        −0.49                  1-Isothiocyanatobutane[\*](#t3f1){ref-type="table-fn"}
  10       19.913     (M+NH~4~)^+^   392.4382   410.4720   C~28~ H~56~               95.74        0.02                   1-Octacosene[\*](#t3f1){ref-type="table-fn"}
  11       8.497      (M+Na)^+^      303.1824   326.1717   C~18~H~25~NO~3~           93.54        3.33                   1-O-Desmethyltetrabenazine
  12       6.266      (M+H)^+^       129.0429   130.0503   C~5~H~7~NO~3~             94.98        −2.57                  1-Pyrroline-4-hydroxy-2-carboxylate
  13       7.633      (M+H)^+^       365.1324   366.1397   C~14~H~23~NO~10~          98.61        −0.58                  2-(acetylamino)-1,5-anhydro-2-deoxy-4-O-b-D-galactopyranosyl-D-arabino-Hex-1-enitol
  14       15.590     (M+H)^+^       171.1087   172.1160   C~9~H~17~NS               90.62        −3.11                  2,5-Dihydro-4,5-dimethyl-2-(1-methylpropyl)thiazole[\*](#t3f1){ref-type="table-fn"}
  15       7.631      (M+H)^+^       291.0958   292.1030   C~11~H~17~NO~8~           98.24        −1.31                  2,7-Anhydro-alpha-N-acetylneuraminic acid
  16       8.822      (M+NH~4~)^+^   418.1835   436.2172   C~19~H~30~O~10~           98.30        1.05                   2-\[4-(3-Hydroxypropyl)-2-methoxyphenoxy\]-1,3-propanediol 1-glucoside
  17       8.685      (M+H)^+^       113.0843   114.0917   C~6~H~11~NO               86.02        −2.34                  2-Acetylpyrrolidine[\*](#t3f1){ref-type="table-fn"}
  18       5.701      (M+NH~4~)^+^   155.0950   173.1288   C~8~H~13~NO~2~            86.86        −2.51                  2-Amino-2-Norbornanecarboxylic acid
  19       5.702      (M+H)^+^       190.0958   191.1029   C~7~H~14~N~2~O~4~         90.69        −2.50                  2-Amino-4-\[(2-hydroxy-1-oxopropyl)amino\]butanoic acid
  20       7.725      (M+NH~4~)^+^   239.1067   257.1405   C~14~H~13~N~3~O           81.23        −3.70                  2-amino-a-phenyl-1H-Benzimidazole-5-methanol
  21       10.087     (M+NH~4~)^+^   94.0785    112.1124   C~7~H~10~                 86.34        −2.46                  2-Methyl-1,3-cyclohexadiene
  22       7.103      (M+H)^+^       155.0701   156.0774   C~6~H~9~N~3~O~2~          84.30        −4.09                  3-(Pyrazol-1-yl)-L-alanine
  23       6.949      (M+NH~4~)^+^   118.0421   136.0759   C~8~H~6~O                 87.41        −1.96                  3,5,7-Octatriyn-1-ol
  24       7.656      (M+NH~4~)^+^   477.1901   495.2239   C~26~H~27~N~3~O~6~        93.78        −0.31                  3,5-Pyridinedicarboxylic acid, 2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-\[methyl(phenylmethyl)amino\]
  25       9.346      (M+H)^+^       186.1374   187.1449   C~9~H~18~N~2~O~2~         96.27        −3.33                  3-\[(3-Methylbutyl)nitrosoamino\]-2-butanone
  26       6.347      (M+NH~4~)^+^   129.0791   147.1129   C~6~H~11~NO~2~            99.35        −0.98                  3-acetamidobutanal
  27       7.395      (M+H)^+^       194.1061   195.1134   C~10~H~14~N~2~O~2~        85.27        −2.80                  3-Hydroxy-N-glycyl-2,6-xylidine (3-Hydroxyglycinexylidide)
  28       7.632      (M+H)^+^       196.0377   197.0449   C~9~H~8~O~5~              85.10        −2.44                  3-Methoxy-4,5-methylenedioxybenzoic acid
  29       19.921     (M+NH~4~)^+^   278.2972   296.3311   C~20~H~38~                85.63        0.46                   3Z,6Z-Eicosadiene
  30       10.783     (M+H)^+^       218.1424   219.1495   C~13~H~18~N~2~O           92.62        −2.42                  4-\[2-(Propylamino)ethyl\]-1,3-dihydro-2H-indol-2-one
  31       7.627      (M+Na)^+^      145.0766   168.0658   C~9~H~9~N~2~              86.63        0.02                   4-Aminomethylindole
  32       8.253      (M+NH~4~)^+^   153.1156   171.1493   C~9~H~15~NO               92.51        −1.46                  4-Butyl-2,5-dimethyloxazole
  33       5.641      (M+NH~4~)^+^   167.1316   185.1654   C~10~H~17~NO              85.56        −3.51                  4-Butyl-2-ethyl-5-methyloxazole
  34       10.175     (M+H)^+^       104.0373   105.0446   C~6~H~4~N~2~              87.29        1.25                   4-Cyanopyridine
  35       8.933      (M+H)^+^       466.2196   467.2267   C~19~H~30~D~3~N~3~O~8~S   87.39        −4.25                  4-hydroxy Nonenal Glutathione-d3
  36       6.351      (M+H)^+^       166.0379   167.0452   C~7~H~6~N~2~O~3~          83.68        −0.52                  4-Hydroxy-3-nitrosobenzamide
  37       8.457      (M+NH~4~)^+^   129.0430   147.0769   C~5~H~7~NO~3~             96.21        −2.91                  4-Oxoproline[\*](#t3f1){ref-type="table-fn"}
  38       6.327      (M+NH~4~)^+^   168.0903   186.1241   C~8~H~12~N~2~O~2~         86.78        −2.26                  4-PIOL
  39       8.928      (M+NH~4~)^+^   139.0638   157.0977   C~7~H~9~NO~2~             86.17        −3.48                  5-Acetyl-2,4-dimethyloxazole
  40       7.722      (M+NH~4~)^+^   267.1016   285.1354   C~15~H~13~N~3~O~2~        81.08        −3.24                  5-benzyl-5-(pyridin-3-yl)imidazolidine-2,4-dione
  41       7.815      (M+NH~4~)^+^   165.1159   183.1497   C~10~H~15~NO              98.24        −3.05                  5-Methyl-2-(1-pyrrolidinyl)-2-cyclopenten-1-one[\*](#t3f1){ref-type="table-fn"}
  42       7.400      (M+H)^+^       241.1067   242.1140   C~10~H~15~N~3~O~4~        86.34        −1.88                  5-Methyldeoxycytidine
  43       9.361      (M+Na)^+^      597.3489   620.3383   C~31~H~51~NO~10~          89.94        4.09                   5-O-β-D-Mycaminosyltylonolide
  44       7.658      (M+NH~4~)^+^   139.0999   157.1337   C~8~H~13~NO               92.23        −1.66                  5-Pentyloxazole
  45       7.406      (M+H)^+^       172.0851   173.0924   C~7~H~12~N~2~O~3~         97.82        −1.94                  5-δ-Hydroxybutyl Hydantoin
  46       8.150      (M+Na)^+^      585.2945   608.2836   C~33~H~39~N~5~O~5~        91.39        1.04                   8',10'- Dihydroxydihydroergotamine
  47       6.927      (M+H)^+^       216.0755   217.0829   C~8~H~12~N~2~O~5~         95.52        −4.14                  8-Hydroxyalanylclavam
  48       7.919      (M+NH~4~)^+^   228.1364   246.1703   C~12~H~20~O~4~            86.63        −1.26                  9,12-dioxo-dodecanoic acid
  49       16.039     (M+NH~4~)^+^   250.2300   268.2639   C~17~H~30~O               86.18        −1.19                  9S,10R-Epoxy-3Z, 6Z-octadecadiene[\*](#t3f1){ref-type="table-fn"}
  50       19.926     (M+NH~4~)^+^   364.4068   382.4407   C~26~H~52~                99.78        0.22                   9Z-Hexacosene[\*](#t3f1){ref-type="table-fn"}
  51       6.756      (M+NH~4~)^+^   217.0856   235.1194   C~11~H~11~N~3~O~2~        86.25        −2.08                  Acetylhydrazinopthalazinone
  52       9.279      (M+NH~4~)^+^   245.1170   263.1508   C~13~H~15~N~3~O~2~        96.87        −2.15                  Acetyltryptophanamide
  53       4.538      (M+H)^+^       135.0551   136.0623   C~5~H~5~N~5~              84.51        −4.22                  Adenine[\*](#t3f1){ref-type="table-fn"}
  54       7.198      (M+H)^+^       243.1221   244.1298   C~10~H~17~N~3~O~4~        85.40        −0.95                  Ala Gly Pro
  55       6.934      (M+NH~4~)^+^   236.1165   254.1504   C~12~H~16~N~2~O~3~        97.31        −1.88                  Alanyl-DL-Phenylalanine
  56       3.734      (M+H)^+^       226.1074   227.1145   C~9~H~14~N~4~O~3~         87.75        −3.48                  Alanyl-Histidine[\*](#t3f1){ref-type="table-fn"}
  57       8.374      (M+H)^+^       232.1578   233.1652   C~14~H~20~N~2~O           85.03        −0.85                  Albine
  58       6.159      (M+NH~4~)^+^   141.0796   159.1134   C~7~H~11~NO~2~            85.48        −4.19                  Arecaidine
  59       7.686      (M+H)^+^       271.1650   272.1723   C~11~H~21~N~5~O~3~        86.06        −1.91                  Arginyl-Proline
  60       7.155      (M+H)^+^       279.1216   280.1289   C~13~H~17~N~3~O~4~        85.73        1.14                   Asn Phe
  61       9.361      (M+NH~4~)^+^   378.1906   396.2245   C~18~H~26~N~4~O~5~        99.55        −0.62                  Asn Val Phe
  62       5.759      (M+H)^+^       368.1330   369.1404   C~15~H~20~N~4~O~7~        84.38        0.41                   Asn-Lys-OH
  63       3.515      (M+Na)^+^      349.1122   372.1015   C~12~H~19~N~3~O~9~        98.31        −0.19                  Asp Thr Asp
  64       7.189      (M+Na)^+^      559.3144   582.3037   C~31~H~45~NO~8~           94.22        0.15                   Auriculine
  65       3.073      (M+NH~4~)^+^   173.0434   191.0772   C~5~H~7~N~3~O~4~          87.00        1.51                   Azaserine
  66       14.410     (M+NH~4~)^+^   290.1788   308.2126   C~20~H~22~N~2~            83.40        −1.75                  Azatadine
  67       4.411      (M+NH~4~)^+^   472.2283   490.2622   C~27~H~36~O~5~S           93.08        0.12                   BAY-u9773
  68       7.655      (M+NH~4~)^+^   165.0796   183.1135   C~9~H~11~NO~2~            85.21        −4.05                  Benzocaine
  69       9.276      (M+H)^+^       234.1483   235.1557   C~12~H~18~N~4~O           94.24        −1.09                  Benzoylagmatine
  70       8.382      (M+Na)^+^      365.1733   388.1628   C~21~H~23~N~3~O~3~        82.56        1.83                   Brevianamide B
  71       3.342      (M+H)^+^       109.0644   110.0717   C~5~H~7~N~3~              96.49        −4.13                  Brunfelsamidine[\*](#t3f1){ref-type="table-fn"}
  72       8.118      (M+H)^+^       643.3329   644.3407   C~35~H~49~NO~10~          80.90        4.29                   Buprenorphine 3-O-glucuronide
  73       7.511      (M+NH~4~)^+^   224.1165   242.1504   C~11~H~16~N~2~O~3~        84.08        −2.03                  Butalbital
  74       6.960      (M+H)^+^       212.1166   213.1240   C~10~H~16~N~2~O~3~        80.31        −2.26                  Butethal
  75       6.757      (M+H)^+^       278.1270   279.1342   C~14~H~18~N~2~O~4~        95.45        −1.14                  Carboxy-PTIO
  76       8.511      (M+H)^+^       607.3124   608.3200   C~31~H~41~N~7~O~6~        90.53        −0.90                  Chymostatin
  77       17.086     (M+H)^+^       127.1365   128.1437   C~8~H~17~N                86.60        −2.89                  Coniine[\*](#t3f1){ref-type="table-fn"}
  78       6.940      (M+H)^+^       176.0947   177.1028   C~10~H~12~N~2~O           82.06        1.45                   Cotinine
  79       9.360      (M+Na)^+^      203.1303   226.1195   C~13~H~17~NO              96.10        3.31                   Crotamiton
  80       9.356      (M+H)^+^       224.1892   225.1965   C~13~H~24~N~2~O           93.91        −1.45                  Cuscohygrine
  81       7.537      (M+H)^+^       244.1215   245.1287   C~14~H~16~N~2~O~2~        86.62        −1.11                  Cyclo(L-Phe-L-Pro)
  82       6.992      (M+H)^+^       227.0914   228.0986   C~9~H~13~N~3~O~4~         95.88        −3.67                  Deoxycytidine
  83       9.360      (M+H)^+^       249.1484   250.1556   C~13~H~19~N~3~O~2~        93.27        −2.74                  Desethyl-N -acetylprocainamide
  84       8.511      (M+H)^+^       308.1534   309.1601   C~19~H~20~N~2~O~2~        86.91        −3.03                  DMXB-A
  85       5.307      (M+H)^+^       115.0636   116.0709   C~5~H~9~NO~2~             92.37        −2.15                  D-Proline
  86       7.816      (M+H)^+^       491.2724   492.2797   C~27~H~41~NO~5~S          86.49        −3.72                  Epothilone D
  87       6.928      (M+H)^+^       204.0900   205.0974   C~11~H~12~N~2~O~2~        83.85        −0.71                  Ethotoin
  88       8.746      (M+NH~4~)^+^   261.1004   279.1341   C~14~H~15~NO~4~           85.03        −0.98                  Ethyl 1-benzyl-3-hydroxy- 2-oxo\[5H\]pyrrole-4-carboxylate
  89       9.297      (M+NH~4~)^+^   373.1958   391.2294   C~15~H~27~N~5~O~6~        83.01        0.87                   Gln Asn Ile
  90       6.351      (M+H)^+^       300.1433   301.1505   C~12~H~20~N~4~O~5~        99.12        0.11                   Gln Gly Pro
  91       7.242      (M+H)^+^       406.2211   407.2284   C~20~H~30~N~4~O~5~        81.92        1.31                   Gln Leu Phe
  92       9.361      (M+H)^+^       421.2328   422.2402   C~20~H~31~N~5~O~5~        96.22        −0.75                  Gln Phe Lys
  93       7.815      (M+H)^+^       356.2061   357.2133   C~16~H~28~N~4~O~5~        98.89        −0.50                  Gln Pro Leu
  94       7.150      (M+Na)^+^      340.1749   363.1642   C~15~H~24~N~4~O~5~        84.85        −0.70                  Gln Pro Pro
  95       6.983      (M+NH~4~)^+^   462.1757   480.2096   C~21~H~26~N~4~O~8~        81.05        −1.42                  Glu Trp Glu
  96       7.169      (M+H)^+^       172.0854   173.0927   C~7~H~12~N~2~O~3~         97.76        −3.55                  Gly Pro
  97       8.482      (M+NH~4~)^+^   311.1121   329.1458   C~13~H~17~N~3~O~6~        82.80        −1.26                  Gly-Lys-OH
  98       14.553     (M+H)^+^       273.2672   274.2746   C~16~H~35~NO~2~           95.51        −1.71                  Hexadecasphinganine
  99       18.610     (M+H)^+^       101.1200   102.1273   C~6~H~15~N                84.30        3.97                   Hexylamine[\*](#t3f1){ref-type="table-fn"}
  100      5.759      (M+H)^+^       226.1065   227.1137   C~9~H~14~N~4~O~3~         99.39        0.42                   His Ala
  101      8.072      (M+H)^+^       302.1386   303.1461   C~15~H~18~N~4~O~3~        82.69        −2.51                  His Phe
  102      7.651      (M+H)^+^       417.2011   418.2082   C~20~H~27~N~5~O~5~        96.58        0.17                   His Tyr Val
  103      7.209      (M+NH~4~)^+^   348.1060   366.1397   C~15~H~16~N~4~O~6~        94.60        2.81                   His-Ala-OH
  104      8.180      (M+H)^+^       302.1382   303.1453   C~15~H~18~N~4~O~3~        84.08        −1.15                  Histidinyl-Phenylalanine
  105      5.675      (M+NH~4~)^+^   254.1383   272.1722   C~11~H~18~N~4~O~3~        98.61        −1.64                  Histidinyl-Valine
  106      6.641      (M+H)^+^       259.1168   260.1239   C~10~H~17~N~3~O~5~        83.20        0.08                   Hydroxypropyl-Gamma-glutamate
  107      7.566      (M+NH~4~)^+^   268.1173   286.1510   C~11~H~16~N~4~O~4~        81.20        −0.36                  Hydroxypropyl-Histidine
  108      5.700      (M+Na)^+^      289.1639   312.1534   C~12~H~23~N~3~O~5~        81.82        −0.36                  Ile Ala Ser
  109      7.815      (M+H)^+^       259.1538   260.1611   C~11~H~21~N~3~O~4~        98.35        −2.20                  Ile Gln
  110      8.447      (M+H)^+^       356.2061   357.2134   C~16~H~28~N~4~O~5~        94.09        −0.48                  Ile Gln Pro
  111      6.481      (M+NH~4~)^+^   180.0538   198.0876   C~8~H~8~N~2~O~3~          85.24        −1.88                  Isonicotinylglycine
  112      18.618     (M+H)^+^       298.1545   299.1616   C~15~H~18~N~6~O           87.32        −0.95                  Iso-Olomoucine[\*](#t3f1){ref-type="table-fn"}
  113      8.688      (M+NH~4~)^+^   268.1315   286.1653   C~14~H~20~O~5~            95.31        −1.49                  Kamahine C[\*](#t3f1){ref-type="table-fn"}
  114      3.088      (M+NH~4~)^+^   151.0606   169.0945   C~5~H~11~O~5~             83.97        0.54                   L-(+)-Arabinose
  115      9.360      (M+H)^+^       210.1373   211.1445   C~11~H~18~N~2~O~2~        97.17        −2.43                  L,L-Cyclo(leucylprolyl)
  116      3.379      (M+Na)^+^      383.1427   406.1318   C~14~H~25~NO~11~          82.74        0.16                   Lacto-N-biose I[\*](#t3f1){ref-type="table-fn"}
  117      6.715      (M+H)^+^       196.1218   197.1292   C~10~H~16~N~2~O~2~        81.16        −3.27                  L-alpha-Amino-1H -pyrrole-1-hexanoic acid
  118      9.355      (M+H)^+^       372.2377   373.2447   C~17~H~32~N~4~O~5~        84.53        −1.09                  Leu Ile Gln
  119      16.538     (M+H)^+^       195.0538   196.0610   C~9~H~9~NO~4~             83.37        −3.51                  Leucodopachrome
  120      6.993      (M+H)^+^       259.1905   260.1976   C~12~H~25~N~3~O~3~        80.87        −3.52                  Leucyl-Lysine
  121      8.258      (M+H)^+^       280.1065   281.1142   C~14~H~12~N~6~O           81.98        2.63                   Levosimendan
  122      8.072      (M+H)^+^       587.3072   588.3144   C~32~H~45~NO~9~           84.74        3.76                   Lipomycin
  123      9.360      (M+H)^+^       252.1846   253.1918   C~14~H~24~N~2~O~2~        96.56        −3.25                  Lupanyl Acid
  124      7.815      (M+NH~4~)^+^   396.2010   414.2348   C~18~H~28~N~4~O~6~        99.69        −0.28                  Lys Ser Tyr
  125      6.826      (M+H)^+^       309.1685   310.1762   C~15~H~23~N~3~O~4~        87.90        1.22                   Lys Tyr
  126      4.413      (M+H)^+^       233.1375   234.1451   C~9~H~19~N~3~O~4~         93.49        0.10                   Lysinoalanine
  127      7.814      (M+NH~4~)^+^   293.1746   311.2084   C~15~H~23~N~3~O~3~        98.62        −2.09                  Lysyl-Phenylalanine
  128      7.162      (M+H)^+^       309.1693   310.1766   C~15~H~23~N~3~O~4~        98.16        −1.39                  Lysyl-Tyrosine
  129      8.464      (M+NH~4~)^+^   109.0530   127.0869   C~6~H~7~NO                84.94        −2.26                  m-Aminophenol
  130      3.516      (M+H)^+^       114.0432   115.0504   C~4~H~6~N~2~O~2~          84.07        −2.51                  Muscimol
  131      8.440      (M+H)^+^       517.2874   518.2948   C~25~H~43~NO~10~          96.46        2.44                   Mycalamide B
  132      7.630      (M+H)^+^       203.0800   204.0871   C~8~H~13~NO~5~            95.68        −2.92                  N2-Acetyl-L-aminoadipate
  133      7.512      (M+H)^+^       130.1109   131.1183   C~6~H~14~N~2~O            86.27        −2.52                  N-Acetylputrescine
  134      6.990      (M+Na)^+^      175.0989   198.0882   C~11~H~13~NO              82.86        4.87                   N-Acetyltranylcypromine
  135      7.539      (M+H)^+^       216.1268   217.1341   C~13~H~16~N~2~O           85.32        −2.70                  Nb-Acetyl-Nb-methyltryptamine
  136      8.747      (M+H)^+^       135.0686   136.0759   C8 H9 N O                 87.70        −1.39                  N-Benzylformamide
  137      9.361      (M+NH~4~)^+^   242.1275   260.1613   C~11~H~18~N~2~O~4~        97.30        −3.29                  N-Hydroxypentobarbital
  138      19.799     (M+Na)^+^      484.3385   507.3275   C~23~H~44~N~6~O~5~        96.28        −2.34                  N-tert-Butyloxycarbonyl-deacetyl-leupeptin
  139      19.253     (M+H)^+^       129.1519   130.1592   C~8~H~19~N                99.07        −1.35                  Octylamine[\*](#t3f1){ref-type="table-fn"}
  140      15.006     (M+H)^+^       255.2568   256.2641   C~16~H~33~NO              95.59        −2.40                  Palmitic amide[\*](#t3f1){ref-type="table-fn"}
  141      9.281      (M+H)^+^       135.0795   136.0868   C~7~H~9~N~3~              94.18        0.93                   p-Aminobenzamidine
  142      10.483     (M+H)^+^       434.2643   435.2716   C~21~H~34~N~6~O~4~        92.06        −0.34                  Phe Arg Leu
  143      8.862      (M+NH~4~)^+^   321.1695   339.2035   C~16~H~23~N~3~O~4~        92.71        −2.04                  Phe Gly Val
  144      9.361      (M+NH~4~)^+^   406.2583   424.2921   C~21~H~34~N~4~O~4~        99.62        −0.75                  Phe Lys Leu
  145      12.812     (M+H)^+^       243.1991   244.2065   C~17~H~25~N               85.35        −1.83                  Phencyclidine
  146      18.627     (M+H)^+^       123.9925   124.9998   C~2~H~5~O~4~P             99.77        0.25                   Phosphonoacetaldehyde
  147      7.154      (M+Na)^+^      542.2482   565.2379   C~23~H~43~O~12~P          83.84        1.95                   PI(14:1(9Z)/0:0)
  148      8.073      (M+H)^+^       245.1633   246.1708   C~13~H~19~N~5~            80.56        3.12                   Pinacidil
  149      7.633      (M+NH~4~)^+^   256.0588   274.0926   C~11~H~12~O~7~            98.80        −2.01                  Piscidic Acid
  150      9.364      (M+Na)^+^      162.1400   185.1293   C~12~H~18~                84.10        4.97                   Pregeijerene
  151      7.517      (M+H)^+^       186.1008   187.1084   C~8~H~14~N~2~O~3~         84.73        −1.94                  Pro Ala
  152      6.991      (M+H)^+^       326.1598   327.1669   C~14~H~22~N~4~O~5~        90.54        −2.52                  Pro Asn Pro
  153      6.934      (M+H)^+^       371.2166   372.2239   C~16~H~29~N~5~O~5~        83.53        0.79                   Pro Gln Lys
  154      7.164      (M+H)^+^       340.1752   341.1822   C~15~H~24~N~4~O~5~        92.07        −1.60                  Pro Gln Pro
  155      7.402      (M+H)^+^       269.1378   270.1451   C~12~H~19~N~3~O~4~        99.48        −1.05                  Pro Gly Pro
  156      7.129      (M+H)^+^       212.1165   213.1239   C~10~H~16~N~2~O~3~        83.55        −2.05                  Pro Pro
  157      6.930      (M+H)^+^       269.1372   270.1446   C~12~H~19~N~3~O~4~        84.07        1.16                   Pro Pro Gly
  158      8.222      (M+H)^+^       375.1797   376.1867   C~19~H~25~N~3~O~5~        90.59        −0.64                  Pro Pro Tyr
  159      5.570      (M+H)^+^       434.2276   435.2349   C~20~H~30~N~6~O~5~        94.18        0.48                   Pro Tyr Arg
  160      7.417      (M+H)^+^       375.1785   376.1861   C~19~H~25~N~3~O~5~        93.97        2.32                   Pro Tyr Pro
  161      8.854      (M+Na)^+^      217.1824   240.1717   C~15~H~23~N               85.69        2.86                   Prolintane
  162      7.820      (M+H)^+^       253.1067   254.1140   C~11~H~15~N~3~O~4~        85.96        −1.67                  Pyricarbate
  163      5.311      (M+NH~4~)^+^   183.0901   201.1237   C~9~H~13~NO~3~            90.47        −3.06                  Racepinephrine
  164      7.516      (M+H)^+^       207.0900   208.0972   C~11~H~13~NO~3~           85.18        −2.13                  Rhexifoline
  165      8.534      (M+H)^+^       244.1584   245.1653   C~15~H~20~N~2~O           88.37        −3.31                  Rhombifoline
  166      9.862      (M+H)^+^       122.1099   123.1172   C~9~H~14~                 86.97        −3.18                  Santene[\*](#t3f1){ref-type="table-fn"}
  167      14.655     (M+H)^+^       299.2829   300.2901   C~18~H~37~NO~2~           95.29        −1.68                  Sphingosine
  168      19.924     (M+H)^+^       213.2457   214.2530   C~14~H~31~N               99.64        −0.40                  Tetradecylamine[\*](#t3f1){ref-type="table-fn"}
  169      19.831     (M+H)^+^       370.1547   371.1620   C~21~H~26~N~2~S~2~        93.67        −2.66                  Thioridazine
  170      4.410      (M+H)^+^       346.2212   347.2284   C~15~H~30~N~4~O~5~        80.69        1.11                   Thr Val Lys
  171      7.568      (M+Na)^+^      493.3240   516.3131   C~28~H~47~NO~4~S          87.00        −2.91                  Tiamulin
  172      7.166      (M+H)^+^       253.1068   254.1142   C~12~H~11~N~7~            83.69        3.12                   Triamterene
  173      6.352      (M+NH~4~)^+^   184.0489   202.0827   C~7~H~8~N~2~O~4~          98.31        −2.85                  Trimidox
  174      9.211      (M+H)^+^       141.1154   142.1228   C~8~H~15~NO               84.62        −0.41                  Tropine
  175      7.102      (M+H)^+^       415.1856   416.1930   C~20~H~25~N~5~O~5~        83.43        −0.12                  Trp Asn Pro
  176      7.010      (M+Na)^+^      418.1850   441.1747   C~20~H~26~N~4~O~6~        80.39        0.59                   Trp Asp Val
  177      7.210      (M+Na)^+^      372.1803   395.1694   C~19~H~24~N~4~O~4~        81.48        −1.36                  Trp Pro Ala
  178      7.817      (M+NH~4~)^+^   303.1583   321.1923   C~16~H~21~N~3~O~3~        96.76        −0.18                  Tryptophyl-Valine
  179      8.506      (M+NH~4~)^+^   423.2000   441.2342   C~20~H~29~N~3~O~7~        88.19        1.20                   Tyr Ile Glu
  180      8.450      (M+NH~4~)^+^   396.2002   414.2345   C~18~H~28~N~4~O~6~        90.22        1.70                   Tyr Ser Lys
  181      6.721      (M+Na)^+^      516.2543   539.2431   C~25~H~36~N~6~O~4~S       80.47        −4.67                  Udenafil
  182      7.666      (M+NH~4~)^+^   387.2258   405.2597   C~20~H~29~N~5~O~3~        80.07        3.07                   Urapidil
  183      6.933      (M+H)^+^       346.1489   347.1562   C~13~H~22~N~4~O~7~        81.66        −0.18                  Val Asp Asn
  184      7.580      (M+H)^+^       401.2058   402.2131   C~20~H~27~N~5~O~4~        82.27        1.29                   Val His Phe
  185      7.655      (M+H)^+^       466.2214   467.2286   C~25~H~30~N~4~O~5~        93.34        0.48                   Val Trp Tyr
  186      7.189      (M+H)^+^       254.1385   255.1458   C~11~H~18~N~4~O~3~        98.02        −2.38                  Valyl-Histidine
  187      9.275      (M+NH~4~)^+^   202.0745   220.1084   C~11~H~10~N~2~O~2~        86.30        −1.26                  Vasicinone
  188      8.958      (M+H)^+^       199.1326   200.1399   C~9~H~17~N~3~O~2~         82.59        −2.81                  Vinyl-L-NIO
  189      5.660      (M+NH~4~)^+^   157.0856   175.1194   C~6~H~11~N~3~O~2~         98.32        −3.12                  V-PYRRO/NO
  190      15.142     (M+H)^+^       229.2410   230.2483   C~14~H~31~NO              84.30        −1.90                  Xestoaminol C[\*](#t3f1){ref-type="table-fn"}
  191      17.087     (M+H)^+^       115.0461   116.0534   C~5~H~9~NS                94.29        −4.73                  xi-2,5-Dihydro-2,4-dimethylthiazole
  192      10.173     (M+H)^+^       374.0342   375.0411   C~17~H~12~C~l2~N~4~O~2~   82.26        −1.30                  α,4-Dihydroxytriazolam
  193      14.599     (M+NH~4~)^+^   222.1991   240.2329   C~15~H~26~O               97.50        −3.28                  β-Caryophyllene Alcohol[\*](#t3f1){ref-type="table-fn"}

Indicate the metabolites that found similarly from pHMG extract under second evaluation screening. RT=Retention time, DB=Database, LC-MS=Liquid chromatography-mass spectrometry, QTOF=Quadrupole time-of-flight

###### 

Information of the metabolites in pHMG extract. The metabolites are identified by QTOF LC-MS with second screening evaluation.

  Number   RT (min)   Ion            Mass       m/z        Molecular formula   Score   DB differences (ppm)   Putatively identified metabolites
  -------- ---------- -------------- ---------- ---------- ------------------- ------- ---------------------- -------------------------------------------------------------------------------------
  1        19.793     (M+Na)^+^      484.3396   507.3290   C~27~H~48~O~7~      96.12   0.87                   (25S)-5alpha-cholestan-3beta,4beta,6alpha,8beta,15alpha,16beta,26-heptol
  2        3.780      (M+H)^+^       99.0322    100.0394   C~4~H~5~NO~2~       86.24   −1.50                  (R)-Dihydromaleimide
  3        14.655     (M+NH~4~)^+^   168.1881   186.2219   C~12~H~24~          98.94   −2.06                  1-Dodecene[\*](#t4f1){ref-type="table-fn"}
  4        19.883     (M+H)^+^       241.2768   242.2840   C~16~H~35~N         86.03   0.67                   1-Hexadecylamine
  5        17.082     (M+H)^+^       203.0807   204.0878   C~9~H~17~NS~2~      93.79   −2.07                  1-Isothiocyanato-7-(methylthio)heptane[\*](#t4f1){ref-type="table-fn"}
  6        15.586     (M+H)^+^       115.0457   116.0530   C~5~H~9~NS          99.79   −1.42                  1-Isothiocyanatobutane[\*](#t4f1){ref-type="table-fn"}
  7        19.896     (M+NH~4~)^+^   392.4383   410.4722   C~28~H~56~          98.76   −0.37                  1-Octacosene[\*](#t4f1){ref-type="table-fn"}
  8        17.084     (M+H)^+^       171.1085   172.1157   C~9~H~17~NS         96.61   −1.92                  2,5-Dihydro-4,5-dimethyl-2-(1-methylpropyl)thiazole[\*](#t4f1){ref-type="table-fn"}
  9        18.737     (M+H)^+^       170.1303   171.1375   C~10~H~18~O~2~      84.98   2.15                   2,6-Dimethyl-3,7-octadiene-2,6-diol
  10       7.676      (M+NH~4~)^+^   256.1315   274.1653   C~13~H~20~O~5~      98.83   −1.55                  2-\[4-(3-Hydroxypropyl)-2-methoxyphenoxy\]-1,3-propanediol
  11       7.678      (M+H)^+^       113.0845   114.0918   C~6~H~11~NO         98.61   −3.80                  2-Acetylpyrrolidine[\*](#t4f1){ref-type="table-fn"}
  12       14.532     (M+H)^+^       105.0790   106.0863   C~4~H~11~NO~2~      84.69   −0.41                  2-Amino-2-methyl-1,3-propanediol
  13       9.461      (M+H)^+^       144.0422   145.0493   C~6~H~8~O~4~        95.91   0.31                   2-Hydroxy-2-(hydroxymethyl)-2H-pyran-3(6H)-one
  14       9.859      (M+H)^+^       101.0844   102.0916   C~5~H~11~NO         96.89   −3.15                  2-methylbutanal oxime
  15       8.921      (M+H)^+^       209.1423   210.1496   C~12~H~19~NO~2~     84.38   −3.50                  3,4-dimethoxymethamphetamine
  16       19.503     (M+NH~4~)^+^   135.0564   153.0902   C~7~H~7~N~2~O       82.59   −4.21                  4-(Hydroxymethyl)benzenediazonium(1+)
  17       7.839      (M+H)^+^       125.0839   126.0912   C~7~H~11~NO         87.69   1.30                   4-Ethyl-2,5-dimethyloxazole
  18       6.992      (M+H)^+^       129.0430   130.0503   C~5~H~7~NO~3~       82.11   −3.43                  4-Oxoproline[\*](#t4f1){ref-type="table-fn"}
  19       8.905      (M+H)^+^       153.1156   154.1227   C~9~H~15~NO         95.68   −1.34                  5-Butyl-2-ethyloxazole
  20       7.182      (M+NH~4~)^+^   165.1155   183.1491   C~10~H~15~NO        82.05   −0.72                  5-Methyl-2-(1-pyrrolidinyl)-2-cyclopenten-1-one[\*](#t4f1){ref-type="table-fn"}
  21       16.002     (M+NH~4~)^+^   250.2302   268.2640   C~17~H~30~O         85.38   −2.25                  9S,10R-Epoxy-3Z,6Z-octadecadiene[\*](#t4f1){ref-type="table-fn"}
  22       19.912     (M+NH~4~)^+^   364.4070   382.4409   C~26~H~52~          99.67   −0.34                  9Z-Hexacosene[\*](#t4f1){ref-type="table-fn"}
  23       5.021      (M+H)^+^       135.0550   136.0622   C~5~H~5~N~5~        86.53   −3.53                  Adenine[\*](#t4f1){ref-type="table-fn"}
  24       5.761      (M+H)^+^       226.1066   227.1139   C~9~H~14~N~4~O~3~   92.45   0.04                   Alanyl-Histidine[\*](#t4f1){ref-type="table-fn"}
  25       18.616     (M+H)^+^       142.0013   143.0084   C~4~H~2~N~2~O~4~    80.18   0.76                   Alloxan
  26       5.765      (M+H)^+^       109.0641   110.0713   C~5~H~7~N~3~        83.73   −1.28                  Brunfelsamidine[\*](#t4f1){ref-type="table-fn"}
  27       7.804      (M+NH~4~)^+^   922.4758   940.5092   C~44~H~74~O~20~     95.22   1.67                   Capsianoside VI
  28       19.762     (M+NH~4~)^+^   747.4789   765.5129   C~38~H~69~NO~13~    85.36   −2.63                  Clarithromycin
  29       17.082     (M+H)^+^       127.1363   128.1435   C~8~H~17~N          86.72   −1.61                  Coniine[\*](#t4f1){ref-type="table-fn"}
  30       19.949     (M+NH~4~)^+^   703.4523   721.4865   C~36~H~65~NO~12~    80.50   −2.29                  Erythromycin D
  31       13.733     (M+Na)^+^      270.1830   293.1723   C~15~H~26~O~4~      86.19   0.32                   Ethylene brassylate
  32       19.854     (M+NH~4~)^+^   240.2452   258.2791   C~16~H~32~O         85.17   0.68                   hexadeca-9-en-1-ol
  33       19.781     (M+H)^+^       101.1201   102.1274   C~6~H~15~N          87.12   3.51                   Hexylamine[\*](#t4f1){ref-type="table-fn"}
  34       18.616     (M+H)^+^       298.1537   299.1607   C~15~H~18~N~6~O     83.14   1.86                   Iso-Olomoucine[\*](#t4f1){ref-type="table-fn"}
  35       8.676      (M+NH~4~)^+^   268.1312   286.1649   C~14~H~20~O~5~      80.46   −0.63                  Kamahine C[\*](#t4f1){ref-type="table-fn"}
  36       3.375      (M+Na)^+^      383.1426   406.1318   C~14~H~25~NO~11~    94.48   0.36                   Lacto-N-biose I[\*](#t4f1){ref-type="table-fn"}
  37       19.300     (M+H)^+^       129.1511   130.1585   C~8~H~19~N          83.91   4.67                   Octylamine[\*](#t4f1){ref-type="table-fn"}
  38       14.588     (M+H)^+^       255.2565   256.2637   C~16~H~33~NO        98.75   −1.08                  Palmitic amide[\*](#t4f1){ref-type="table-fn"}
  39       9.858      (M+H)^+^       122.1096   123.1169   C~9~H~14~           85.95   −0.42                  Santene[\*](#t4f1){ref-type="table-fn"}
  40       19.911     (M+H)^+^       213.2457   214.2530   C~14~H~31~N         98.18   −0.32                  Tetradecylamine[\*](#t4f1){ref-type="table-fn"}
  41       19.838     (M+H)^+^       229.2406   230.2478   C~14~H~31~NO        97.56   0.01                   Xestoaminol C[\*](#t4f1){ref-type="table-fn"}
  42       14.568     (M+NH~4~)^+^   222.1988   240.2326   C~15~H~26~O         98.81   −2.08                  β-Caryophyllene Alcohol[\*](#t4f1){ref-type="table-fn"}

Indicate the metabolites that found similarly from eHMG extract under second evaluation screening. RT=Retention time, DB=Database, LC-MS=Liquid chromatography-mass spectrometry, QTOF=Quadrupole time-of-flight

Sialic acid is known as the key component of EBN because it is served as the unique quantitative marker for grading the EBN. In this study, sialic acid was identified in the eHMG extraction method with the identity of 2,7-Anhydro-alpha-N-acetylneuraminic acid ([Table-3](#T3){ref-type="table"}). The result agreed with the previous studies that N-acetylneuraminic acid (NANA) is the predominant form of sialic acid in EBN \[[@ref33]-[@ref35]\]. The detected of sialic acid in eHMG extract has further convinced that eHMG extraction method is more suitable as the ideal extraction method.

The type of metabolites present in eHMG and pHMG extracts (from the second screening) was further categorized into five groups based on the macronutrient classification ([Figure-2d](#F2){ref-type="fig"}). The five groups of macronutrients are comprised oligosaccharides, peptides, lipids, nucleosides, and secondary metabolites. There were 192 and 42 metabolites identified from eHMG and pHMG extracts (Tables-3 and 4), respectively. The differences in the type of metabolites between eHMG and pHMG extracts have further supported the preference of the type of metabolites toward each extraction method. Among the macronutrients, eHMG extraction method can extract mostly secondary metabolites, followed by peptides, oligosaccharides, lipids, and nucleosides ([Figure-2d](#F2){ref-type="fig"}). The primary metabolites obtained from this study support the finding from the previous proximate analysis of EBN, which protein is the highest composition followed by carbohydrates and lipids \[[@ref2],[@ref36],[@ref37]\].

The presence of secondary metabolites could most probably explain the recuperative and therapeutic effects of EBN. The secondary metabolite with the identity of O[@ref2]-vinyl 1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate (V-PYRRO/nitric oxide \[NO\]) was found in eHMG extract ([Table-3](#T3){ref-type="table"}). This secondary metabolite acts as NO donor and delivers NO specifically after metabolism by cytochrome P450 in hepatocytes without affecting the NO-sensitive tissues as well as systolic blood pressure \[[@ref38]\]. The *in vivo* study done by Li *et al*. \[[@ref39]\] showed that V-PYRRO/NO is able to protect the hindrance to renal congestion and lipid peroxidation from acetaminophen-induced nephrotoxicity in mice. In addition, V-PYRRO/NO can protect against high-fat diet (HFD)-induced liver steatosis and insulin resistance without affecting the mitochondria biogenesis \[[@ref40]\]. Interestingly, Zhang *et al*. \[[@ref41]\] showed that EBN could prevent HFD-induced insulin resistance by regulating the transcriptional changes in insulin signaling genes. Hence, the presence of V-PYRRO/NO in EBN may explain the protective effect of EBN against the HFD-induced damages. In short, from this study, it is believed that the study on secondary metabolites profiling in EBN in the future is crucial and not to be neglected.

A polysaccharide with an identity of chondroitin was identified from the first screening of eHMG extract ([Table-1](#T1){ref-type="table"}), in which the discovery of water-soluble chondroitin is similar to the finding of Nakagawa *et al*. in EBN \[[@ref42]\]. Chondroitin is a glycosaminoglycan that acts as a chondroprotective agent for the treatment of OA. OA is the lesion of articular cartilage caused by trauma. Since chondroitin is an essential proteoglycan in cartilage, it acts on OA by stimulates the cartilage repair through enhancing the production of the extracellular matrix of cartilage. Besides, chondroitin helps to maintain the viscosity of the synovial fluid to lubricate the joint and therefore reducing the pain of the patient. Furthermore, chondroitin suppresses the inflammatory cytokines such as interleukin-1β that induce the release of matrix metalloproteinases and aggrecanases which cause the degradation of the cartilage \[[@ref43],[@ref44]\]. In an *in vitro* study done by Chua *et al*. on the effects of EBN to OA \[[@ref17]\], the authors reported that EBN can protect articular cartilage from further deterioration by reducing inflammation and enzymatic lesions process and enhancing the cartilage formation simultaneously. Therefore, the effects of EBN on OA might be contributed by chondroitin.

Conclusion {#sec1-4}
==========

There was no single extraction method could provide optimal conditions in extracting all the metabolites from EBN. Therefore, complementary extraction methods should be used in parallel when broader metabolite profiles are required. eHMG extraction method was selected as the ideal extraction method for untargeted profiling the type of polar metabolites in EBN. This is because the number and the type of metabolites detected are the highest in eHMG extracts among the four evaluated extraction methods. Furthermore, the presence of key metabolites of sialic acid has further defined the suitability of eHMG extraction method. Therefore, the findings in this study could offer great potential for enhancement in the industrial EBN extraction process and hence improve the overall EBN yield and bioactivities. Nevertheless, the validation of the structure elucidation and functional assays of interesting metabolites shall be carried out in the future.
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